Key Notes on Revised Schedule M: Compilation

We've created concise notes from the revised schedule M for each point to guide manufacturers in maintaining GMP standards.

707
Key Notes Revised Schedule M Compilation
Key Notes Revised Schedule M Compilation
Rakesh Dahiya

Last Updated on January 15, 2025 by The Health Master

Revised Schedule M

To ensure the production of high-quality drugs, pharmaceutical manufacturers must adhere to 20 key points outlined in the Main Principles for Good Manufacturing Practices (GMP) in revised schedule M.

We’ve created concise notes from the revised schedule M for each point to guide manufacturers in maintaining GMP standards.

Click the below links to read more:

1. Pharmaceutical Quality System

Key Notes on Revised Schedule M: Point No. 1 – Pharmaceutical Quality System

2. Quality Risk Management

Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management

3. Good Manufacturing Practice (GMP)

Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)

4. Sanitation and Hygiene

Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

5. Qualification and validation

Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation

6. Complaints and Adverse reaction

Key Notes on Revised Schedule M: Point No. 6 – Complaints and Adverse reaction

7. Product Recall

Key Notes on Revised Schedule M: Point No. 7 – Product Recall

8. Change Control

Key Notes on Revised Schedule M: Point No. 8 – Change Control

9. Production under Loan License

Key Notes on Revised Schedule M: Point No. 9 – Production under Loan License

10. Self Inspection

Key Notes on Revised Schedule M: Point No. 10 – Self Inspection

11. Personnel

Key Notes on Revised Schedule M: Point No. 11 – Personnel

12. Premises

Key Notes on Revised Schedule M: Point No. 12 – Premises

13. Equipment

Key Notes on Revised Schedule M: Point No. 13 – Equipment

14. Materials

Key Notes on Revised Schedule M: Point No. 14 – Materials

15. Reference Standards

Key Notes on Revised Schedule M: Point No. 15 – Reference Standards

16. Waste materials

Key Notes on Revised Schedule M: Point No. 16 – Waste materials

17. Documentation

Key Notes on Revised Schedule M: Point No. 17 – Documentation

18. Good practices in production

Key Notes on Revised Schedule M: Point No. 18 – Good practices in production

19. Good practices in quality control

Key Notes on Revised Schedule M: Point No. 19 – Good practices in quality control

20. Computerised systems

Key Notes on Revised Schedule M: Point No. 20 – Computerised systems

Tablets & Capsules (OSDF)

Key Notes on Revised Schedule M: Tablets & Capsules (OSDF)

Oral Liquids

Key Notes on Revised Schedule M: Oral Liquids

Topical Products (External Preparations)

Key Notes on Revised Schedule M: Topical Products (External Preparations)

Sterile products {Steroids (Anabolic, Androgenic) or Cytotoxic Substances}

Key Notes on Revised Schedule M: Sterile products

Sex Hormones {Steroids (Anabolic, Androgenic) or Cytotoxic Substances}

Key Notes on Revised Schedule M: Sex Hormones

Biological products

Key Notes on Revised Schedule M: Biological products

Key Notes on Revised Schedule M: API (Active Pharmaceutical Ingredients) ………………………coming soon


Compiled by:
Rakesh DahiyaSDCO cum Licensing Authority, FDA Haryana


For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news